• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE TAG CONFORMABLE THORACIC STENT GRAFT WITH ACTIVE CONTROL SYSTEM; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE TAG CONFORMABLE THORACIC STENT GRAFT WITH ACTIVE CONTROL SYSTEM; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number TGMR373720
Device Problem No Apparent Adverse Event (3189)
Patient Problems Aneurysm (1708); Vascular Dissection (3160)
Event Date 06/28/2020
Event Type  Death  
Manufacturer Narrative
Patient medical history includes but is not limited to: tevar, extreme hypertension.Patient medications include but are not limited to: labetalol, losartin, lasix.A review of the manufacturing records for the device was unable to be conducted as no lot number was available; as such, no udi was generated.According to the instructions for use (ifu) for the gore® tag® thoracic endoprosthesis; adverse events that may occur include, but are not limited to: dissection, perforation, or rupture of the aortic vessel and surrounding vasculature.
 
Event Description
On (b)(6) 2020, this patient underwent endovascular treatment for a descending thoracic aortic aneurysm and was implanted with two conformable gore® tag® thoracic endoprostheses (ctag).The patient tolerated the procedure.It was noted that the patient had a bovine arch.On (b)(6) 2020, the patient presented emergently with a ruptured thoracic type b dissection and underwent surgical bypass of the left subclavian artery to the innominate artery.Additionally, an aorta bi-fem bypass of the superior mesenteric artery to the renals was performed.An additional ctag was implanted within the surgical graft and extended down to the abdominal aorta.The patient tolerated the procedure however is still under anesthesia.The physician reports the rupture is thought to have been due to persistent perfusion into the false lumen and thrombosis of the false lumen.There was no allegation of deficiency as to the devices by the physician, all devices performed as intended.
 
Event Description
On (b)(6) 2020, it was reported that the patient expired.A cause of death was unknown.
 
Manufacturer Narrative
Updated/corrected information: d11: as gore was unable to determine which device was involved in the event if any; additional device(s) implanted include: tgm454515/21961607.
 
Manufacturer Narrative
H6: code 213- a review of the manufacturing records for the device(s) verified that the lot(s) met all pre-release specifications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE TAG CONFORMABLE THORACIC STENT GRAFT WITH ACTIVE CONTROL SYSTEM
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
MDR Report Key10215523
MDR Text Key197098653
Report Number2017233-2020-01008
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
PMA/PMN Number
P040043
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup,Followup,Followup
Report Date 08/07/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/30/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/01/2022
Device Model NumberTGMR373720
Device Catalogue NumberTGMR373720
Was Device Available for Evaluation? No
Date Manufacturer Received06/28/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Death; Hospitalization; Other; Required Intervention;
Patient Age28 YR
Patient Weight105
-
-